Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N JONES

Showing results (701-710 of 818) with videos related to

Pageof 82
Sort By:
Diagnostic Microbiology and Infectious Disease|July 1, 1991
Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centersR N Jones, M A Pfaller, S D Allen, et al.
The American Review of Respiratory Disease|September 1, 1991
Exposure-related declines in the lung function of cotton textile workers. Relationship to current workplace standardsH W Glindmeyer, J J Lefante, R N Jones, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1987
Antimicrobial activity of Ro 19-5247 (T-2525), a new oral cephalosporin, tested against 7,745 recent clinical isolatesR N Jones, P C Fuchs, A L Barry, et al.
Diagnostic Microbiology and Infectious Disease|June 4, 1999
Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and etest method validation. Quality Control Study GroupR N Jones, D M Johnson, M E Erwin, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 1, 1982
Improved tolerance to ischemia in hypertrophied myocardium by preischemic enhancement of adenosine triphosphateR B Peyton, P Van Trigt, G L Pellom, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1979
Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolatesR N Jones, A L Barry, P C Fuchs, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1993
Multilaboratory evaluation of the in vitro activity of 13 beta-lactam antibiotics against 1474 clinical isolates of aerobic and anaerobic bacteriaP R Murray, R N Jones, S D Allen, et al.
Journal of Clinical Microbiology|July 3, 1998
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant GroupM A Pfaller, R N Jones, G V Doern, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1980
Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicinR N Jones, P C Fuchs, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1993
Multicenter comparison of in vitro activities of FK-037, cefepime, ceftriaxone, ceftazidime, and cefuroximeJ A Washington, R N Jones, E H Gerlach, et al.
Pageof 82

Showing results (701-710 of 818) with videos related to

Sort By:
Pageof 82
Diagnostic Microbiology and Infectious Disease|July 1, 1991
Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centersR N Jones, M A Pfaller, S D Allen, et al.
The American Review of Respiratory Disease|September 1, 1991
Exposure-related declines in the lung function of cotton textile workers. Relationship to current workplace standardsH W Glindmeyer, J J Lefante, R N Jones, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1987
Antimicrobial activity of Ro 19-5247 (T-2525), a new oral cephalosporin, tested against 7,745 recent clinical isolatesR N Jones, P C Fuchs, A L Barry, et al.
Diagnostic Microbiology and Infectious Disease|June 4, 1999
Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and etest method validation. Quality Control Study GroupR N Jones, D M Johnson, M E Erwin, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 1, 1982
Improved tolerance to ischemia in hypertrophied myocardium by preischemic enhancement of adenosine triphosphateR B Peyton, P Van Trigt, G L Pellom, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1979
Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolatesR N Jones, A L Barry, P C Fuchs, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1993
Multilaboratory evaluation of the in vitro activity of 13 beta-lactam antibiotics against 1474 clinical isolates of aerobic and anaerobic bacteriaP R Murray, R N Jones, S D Allen, et al.
Journal of Clinical Microbiology|July 3, 1998
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant GroupM A Pfaller, R N Jones, G V Doern, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1980
Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicinR N Jones, P C Fuchs, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1993
Multicenter comparison of in vitro activities of FK-037, cefepime, ceftriaxone, ceftazidime, and cefuroximeJ A Washington, R N Jones, E H Gerlach, et al.
Pageof 82